[ARWR] YoY Quarter Result on 30-Sep-2019 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
25-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q4]
Profit Trend
QoQ- -42.44%
YoY- 208.77%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 31,575 38,283 7,633 43,293 11,255 8,714 31 217.03%
PBT -82,157 -63,372 -48,430 11,878 -10,759 -10,729 -22,220 24.33%
Tax 3,785 2 2 174 2 2 2 251.49%
NP -85,942 -63,374 -48,433 11,705 -10,761 -10,732 -22,222 25.27%
Tax Rate - - - -1.46% - - - -
Total Cost 117,517 101,657 56,066 31,588 22,016 19,446 22,253 31.94%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -272.18 -165.54 -634.53 27.04 -95.61 -123.16 -71,110.36 -60.43%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.81 -0.61 -0.47 0.12 -0.12 -0.14 -0.31 17.35%
EPS Diluted -0.81 -0.61 -0.47 0.12 -0.11 -0.14 -0.31 17.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.